Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Clover Health Investments A | CLOV | Nov 27, 2024 | 3.42 | +0.59 |
CLPS | CLPS | Nov 27, 2024 | 1.11 | +0.91 |
CMBS Bond Ishares | CMBS | Nov 27, 2024 | 47.52 | -0.06 |
CME Group A | CME | Nov 27, 2024 | 237.33 | +1.25 |
CMS Energy | CMS | Nov 27, 2024 | 70.49 | +0.06 |
CMS Energy C Pref | CMS-C | Nov 27, 2024 | 19.49 | +0.26 |
CN Energy Group A | CNEY | Nov 27, 2024 | 0.36 | -4.56 |
CNA Financial | CNA | Nov 27, 2024 | 50.27 | +0.54 |
CNB Financial | CCNE | Nov 27, 2024 | 28.22 | -0.14 |
CNB Financial Pref | CCNEP | Nov 27, 2024 | 24.95 | +1.01 |
CNFinance ADR | CNF | Nov 27, 2024 | 0.95 | -0.32 |
CNH Industrial N.V. | CNH | Nov 27, 2024 | 12.54 | +1.29 |
CNO Financial Group | CNO | Nov 27, 2024 | 40.16 | -0.84 |
CNS Pharmaceuticals | CNSP | Nov 27, 2024 | 0.12 | -0.86 |
CNX Resources | CNX | Nov 27, 2024 | 40.34 | -1.08 |
Co-Diagnostics | CODX | Nov 27, 2024 | 0.94 | +0.68 |
CO2 Energy Transition Unit | NOEMU | Nov 27, 2024 | 9.98 | 0.00 |
Coastal Financial | CCB | Nov 27, 2024 | 77.23 | -0.09 |
Coca-Cola | KO | Nov 27, 2024 | 64.43 | -0.19 |
Coca-Cola Consolidated | COKE | Nov 27, 2024 | 1 312.40 | -2.42 |
Coca-Cola Europacific Partners | CCEP | Nov 27, 2024 | 77.63 | -0.40 |
Coca-Cola FEMSA ADR | KOF | Nov 27, 2024 | 79.33 | +0.20 |
Cocrystal Pharma | COCP | Nov 27, 2024 | 2.10 | -0.94 |
Coda Octopus | CODA | Nov 27, 2024 | 8.84 | -2.00 |
Codere Online Luxembourg | CDRO | Nov 27, 2024 | 7.60 | -2.94 |
Codexis | CDXS | Nov 27, 2024 | 4.59 | +0.66 |
Coeptis Therapeutics | COEP | Nov 27, 2024 | 0.20 | +1.71 |
Coeur Mining | CDE | Nov 27, 2024 | 6.49 | +1.72 |
Coffee Holding Company | JVA | Nov 27, 2024 | 3.53 | +3.52 |
Cogent Biosciences | COGT | Nov 27, 2024 | 9.58 | -0.47 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.